suzamed Temp Display Insulin Cooler Travel Case, 2PCS 150g Ice Pack, Green
Organizers & Travel Kits - 产品分析报告
  • Benchmark ASIN
    B0FPQ6461V
  • Marketplace
    US
  • Category ID
    3761461
  • Analyzed Products
  • Keyword
    home health supplies
  • Price Range
    -
  • Minimum Net Profit Margin
    10.00%
  • MOQ
    100
  • Est. Purchasing Cost
    ¥8.99estimated
  • Data Date
    2026-07-31
  • Your Budget (for new listing) (CNY)
    ¥500,000.00
Profitability Difficulty
Unknown
Unknown - Insufficient New Releases
Newly Released Counts (All Brands)
2
New Brand (2)
Old Brand (0)
Success rate (all brands)
50.00%
New Brand (50.00%)
Old Brand (0%)
Most products net profit margin range
N/A
Listing

Report summary from Keble AI Agent: Listing

结论很明确:这个市场现在不值得进入。 你有50万人民币,看起来够做单个ASIN的启动,但市场里真正可复制的成功样本太少,近期新品牌不是形成稳定增长,而是只有 suzamed 这一家在 2 个新品里做出 1 个成功、1 个失败,说明这更像靠单点差异化撑起来的窄机会,不是适合常规打法的赛道。

证据也很直接:当前只看到 1 个新品牌 suzamed,品牌层面的新品成功率是 50%,但样本只有 2 个新品,不能算强证据;更关键的是,唯一赚钱的 B0FPQ6461V 只是做到 12.4% 利润率,售价 14.99 美元,月销 100 单,月营收约 1,499 美元,前期投入约 7,465 美元,它能跑出来靠的是温度显示窗 + 绿色外观差异 + 基于旧款做功能升级,不是低价硬拼。失败款 B0GX96TKCK 则是同质化明显、功能太基础、竞争太强,说明这个细分已经开始逼近价格战和功能重复的状态;而且从时间上看,2025/9 有 1 个成功新品,2026/4 有 1 个失败新品,没有看到持续变好的趋势,反而是新品试错后很快失效。这里没有看到 30 个以上新品牌涌入的那种全面过热,但也完全没有形成足够强的开放机会,属于低可复制性、偏窄、对创新要求高的市场。

Recommended Products Features Direction
B0FPQ6461V
Why do customers choose it?
  • 绿色机身在同类胰岛素保温包里较少见,视觉识别度更高
  • 带实时温度显示窗的竖长便携保温盒造型,区别于普通纯收纳式保温包
  • 内置温度显示,可直观看到包内温度并辅助控制胰岛素安全存储
  • 面向需要随身携带胰岛素、血糖仪和其他糖尿病用品的出行用户
  • Sales
    Avg. price: $14.99|Latest price: $14.99|Approx. recent monthly revenue: $1,499.00 (100 pcs)|Net profit margin: 12.40%
    B0GX96TKCK
    Why do customers choose it?
  • 外观与竞品同质化明显,属于常见的拉链保温药盒/冰袋组合形态
  • 仅有温度显示+双冰袋的基础组合,功能点与同类产品高度重叠
  • 糖尿病胰岛素随身冷藏出行人群,但该细分已被大量同类产品覆盖
  • Sales
    Avg. price: -|Latest price: -|Approx. recent monthly revenue: - (- pcs)|-

    These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.

    New Brands
    VS
    Old Brands
    1 new brands0 old brands
    1 brands have new listings0 brands have new listings
    2 new listings0 new listings
    1 succeeded
    0 succeeded
    1 failed
    0 failed

    Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.

    New Brands

      How much did others invest?

      Collapse
    • #Budget Requirement

      Listing

      结论很明确:这个市场不适合现在进入。 你有50万人民币,表面上足以覆盖单个ASIN前几个月的采购、头程、仓储和基础投放,但市场里新产品成功率只有50%,而且当前看到的真正可复制案例只有1个,失败案例也有1个;更关键的是,唯一成功的新品仍然只做到12.4%利润率,说明这不是高利润空间,而是靠功能差异和投入硬撑出来的市场。

      Early sourcing + logistics + marketing budget (USD)
      N/A
      Explains the budget

      With all these investments, who has profitable new releases

      How many new listings are released by old brands?
      0.00%
      New listing success rate (new brands):
      50.00%
      Which new brands have these successful new listings?
      Alternatives
      1. 一次性保温药盒/保温袋:用铝膜保温袋或简易保温盒替代专用胰岛素旅行箱,价格更低、Amazon上更常见,适合短途出行或临时携带。
      2. 普通小型硬壳收纳盒 + 独立冰袋:用通用EVA收纳盒搭配可重复使用冰袋,能装胰岛素笔和血糖仪,成本通常更低,也更容易按需组合。
      3. 医药冷藏背包内胆/通用冷藏包:如果不需要“温度显示”,选择普通便携冷藏包即可获得类似保冷效果,款式更多、购买门槛更低。
      4. 胰岛素笔保护套/保温套:只保护单支或少量胰岛素笔,体积更小、更便携,价格通常明显低于整套旅行冷藏盒。
      5. 药品冷链运输一次性保温包:适合偶发长途出行或临时携药,不追求重复使用和高级功能时,这是更省事的替代方案。

      Alternative solutions may pose a risk to your investment in certain markets.

    • #Brands Investment Analysis

      Listing

      这个市场可以直接判定为可进入,但不适合小预算硬闯;它不是低门槛红海,也没有出现你定义的那种“新品牌大规模涌入”警报。目前样本里只有 suzamed 一个新品牌,成功率 50%,但真正能拿来当参考的只有 1 个盈利款和 1 个失败款,样本太小,无法证明市场已经形成稳定、可复制的赢家模型。

      suzamed
      Most investment in new productsNew products with Highest revenueLeast investment in new products
      suzamed Temp Display Insulin Cooler Travel Case, 2PCS 150g Ice Pack, Green
      Recent Monthly Revenue (USD):$1,499.00(100pcs/month)
      B0FPQ6461V (4.5/5 (393 Reviews))Brand is a new entry in this market
      New ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
    • #Differentiations

      Unique productsCommon products
      suzamed Temp Display Insulin Cooler Travel Case, 2PCS 150g Ice Pack, Green
      Differentiation:
      1. Product features and designs are too common without differentiation
      B0FPQ6461V (4.5/5 (393 Reviews))Brand is a new entry in this market
      New ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
      suzamed Temp Display Insulin Cooler Travel Case, 2PCS 150g Ice Pack,
      Differentiation:
      1. Product features and designs are too common without differentiation
      B0GX96TKCKBrand is a new entry in this market
      New ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
    • What net profit margin are others making?

      Collapse
    • #Net Profit Margins: All vs New

      Listing

      这个市场不值得进入:新品牌样本里只有1个新上架产品盈利、1个新上架产品亏损,盈利率50%只是样本太小,不能掩盖后续新品已经失败的信号;更关键的是,真正可复制的低门槛小品牌成功案例并不存在,靠普通同质化很难赢。 现在能看到的唯一赚钱样本是 suzamed 的 B0FPQ6461V,但它是靠功能差异化和温度显示卖点跑出来的,不是靠低价硬拼。

      Profitability difficulty
      Unknown - Insufficient New Releases

      All products distribution on different profit levels

      All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.

      x < -10.0%
      -10.0% <= x < 0.0%
      0.0% <= x < 10.0%
      10.0% <= x < 20.0%
      20.0% <= x < 30.0%
      30.0% <= x < 40.0%
      x >= 40.0%
      other

      New products distribution on different profit levels

      This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'

      x < -10.0%
      -10.0% <= x < 0.0%
      0.0% <= x < 10.0%
      10.0% <= x < 20.0%
      20.0% <= x < 30.0%
      30.0% <= x < 40.0%
      x >= 40.0%
      other
    • #Top Products by Net Profit Margin

      Top 20 Profitable Products

      Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.

      B0FPQ6461V
      B0FPQ6461V
      suzamed
      2025-09-07
      Yes
      $14.99
      100pcs
      $1499.0
      12.4%
      $185.88

      Top 20 Profitable New Products

      Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.

      B0FPQ6461V
      B0FPQ6461V
      suzamed
      2025-09-07
      Yes
      $14.99
      100pcs
      $1499.0
      12.4%
      $185.88
    • Is this a good time to enter the market?

      Collapse
    • #New Product Success Rates

      Listing

      这个市场不值得进入:当前样本里只有 2 个新发布产品,盈利率 50% 看起来不低,但真正可复制的成功只有 1 个,而且它是靠差异化功能+旧款基础上改造才跑出来的;另一款同品牌新品直接失败,说明这个细分对普通新品很挑剔,不是稳定可扩张的机会。对小卖家来说,能“合法、正常”做成的空间很小;对大品牌来说也不是好市场,因为利润并没有形成可持续的强势共识,反而更像是靠单点创新撑起来的窄机会。

      证据很直接:suzamed 这个新品牌目前 2 个 ASIN,1 个盈利、1 个不盈利,品牌成功率只有 50%。盈利款 B0FPQ6461V 售价 14.99 美元,月销约 100 单,月营收 1,499 美元,利润率 12.4%,但它的成功原因不是低价,而是“温度显示窗 + 造型差异化”这种明确区隔;进入门槛对应的前期投入约 7,465 美元,其中广告约 1,677 美元。失败款 B0GX96TKCK 则因为同质化明显、功能点太基础、市场被大量同类覆盖而卖不动。更关键的是,当前没有看到旧品牌大量统治成功榜,也没有看到新品牌成功率高到说明市场开放;相反,样本极少、可复制成功少,说明这不是一个适合靠常规打法切入的赛道。

      New products success rate.

      What is the ratio of profitable products

      Profitable (Unidentifiable released date)
      Profitable (Old product)
      Profitable (New product)
      Profitable (New product on old listing)
      New products but non profitable

      Profitable new products divide by brands

      What is the ratio of different brands owning all profitable new products

      suzamed

      Nonprofitable new products divide by brands

      What is the ratio of different brands owning all nonprofitable new products

      suzamed
    • #Success Rate by Entry Time

      Listing

      这个市场不值得进入,已经接近或进入同质化价格战区。 目前能看到的近两次新品牌入场只有 2 个样本,结果一胜一负,成功率仅 50%,但更关键的是失败样本已经明确指出“同质化明显、竞争极强”,而且新品牌的成功也不是靠低门槛普适打法,而是靠“基于旧款改良 + 功能差异化”。

      证据很直接:新品牌 suzamed 的成功款 B0FPQ6461V,售价 14.99 美元,月营收 1499 美元,成功点是实时温度显示、绿色外观差异、基于旧款做功能升级;但同品牌另一款 B0GX96TKCK 则直接失败,原因是缺乏独特性、细分市场太小或竞争太激烈、利润空间太薄。从时间上看,2022-2024 年几乎没有可见新品牌成功样本,2025 年 9 月出现 1 个成功,2026 年 4 月又出现 1 个失败,说明近期并没有形成稳定上升的成功趋势,反而更像是零星试错、竞争加重。同时,用户预算是 500000 CNY,表面上足够覆盖单个 ASIN 的启动,但这类市场的关键不在首发预算,而在持续差异化、品牌和营销投入;失败款已经证明,只靠基础功能和常规包装根本打不过。

      对两类卖家结论都一样:大品牌能进,但也只是高投入换少量机会;小商家不适合进。 这里没有“<300 评价/年”的真实小商家成功样本,能看到的成功只有 suzamed 这一类新入场品牌,而且它的成功依赖差异化设计,不是低成本复制。更重要的是,失败样本已经显示市场在逼近“要么做出明显创新,要么被埋掉”的状态;如果要硬进,至少要按 B0FPQ6461V 这种路径走,但这不是适合小商家复制的打法。

      How many products released each year

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

      How many products released each month

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

    • #Net Profit Margins by Entry Time

      Different profit ratios of products released in year

      Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.

      Time/Profit%x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other
      202200000000
      202300000000
      202400000000
      202500010000
      202600000001
      ≥ 10% Profitable
      < 10% Unprofitable
      Unidentifiable

      Different profit ratios of products released in month

      Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.

      Time/Profit%x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other
      2025/700000000
      2025/800000000
      2025/900010000
      2025/1000000000
      2025/1100000000
      2025/1200000000
      2026/100000000
      2026/200000000
      2026/300000000
      2026/400000001
      2026/500000000
      2026/600000000
      ≥ 10% Profitable
      < 10% Unprofitable
      Unidentifiable
    • What factors contribute to success or failure?

      Collapse
    • #Case Study

      Success Cases
      suzamed Temp Display Insulin Cooler Travel Case, 2PCS 150g Ice Pack, Green
      Price (USD)
      $14.99
      Released Type
      New Release (2025-09-07)
      Brand is a new entry in this market
      Size and Weight
      21.7 x 12.2 x 6.0 cm, 449.00g

      Profitable Factors

      Based on old ASINDistinct functions and features

      Design & Appearance

      绿色机身在同类胰岛素保温包里较少见,视觉识别度更高, 带实时温度显示窗的竖长便携保温盒造型,区别于普通纯收纳式保温包

      Key Buying Motive

      内置温度显示,可直观看到包内温度并辅助控制胰岛素安全存储

      Target Customers

      面向需要随身携带胰岛素、血糖仪和其他糖尿病用品的出行用户

      Early Investment

      Investment

      Monthly Revenue (Recent) (USD)
      $1,499.00
      100 sold in the past 30 days · as of 2026年7月

      Net Profit Margin

      Sea Freight
      8.64% / 12.40%
      Peak / Non Peak
      Rail Freight
      - / -
      Peak / Non Peak
      Air Freight
      -5.98% / -2.23%
      Peak / Non Peak

      Sales & BSR Performance

    What is Keble?

    Keble is an e-commerce AI Agent that helps sellers solve daily e-commerce issues. This report is generated by Keble AI.

    Analyze Product Opportunity with Keble
    1. One report to tell you whether to enter the market or not, significantly reducing inventory risk.
    Keble AI Agent